Targeted therapy could turn advanced lung cancer into chronic illness: CUHK study

“A Hong Kong co-led global study has found that a targeted therapy can keep more than half of advanced lung cancer patients alive without disease progression for at least seven years, marking a step towards turning the deadly illness into a chronic condition. Researchers from the Chinese University of Hong Kong on Wednesday released the findings of their study, which looked into the efficacy of the third-generation targeted therapy lorlatinib on patients with advanced lung cancer. The study...

Summary generated from the RSS feed of SCMP Hong Kong. All article rights belong to the original publisher. Click through to read the full piece on www.scmp.com/news/hong-kong.